Oryon Cell Therapies launches with $21 million to advance Parkinson’s treatment

Mar 23 (Reuters) – Oryon Cell Therapies emerged from stealth on Monday with $21 million in new funding and early ​clinical data showing signs that its ‌experimental therapy may help restore lost brain function in Parkinson’s patients.

The new tranche brings Oryon’s total funding to $42 million.

Here are some details:

(Reporting by Kamal Choudhury in Bengaluru; Editing by ​Mrigank Dhaniwala)